ArchIntel

JUNE 2, 2021

pharmaceutical industry in 2021 and beyond. The race to create new products against COVID-19 amid the emergence of new mutations is expected to eclipse every other effort in health care and pharmaceuticals this year. pharmaceutical and health care industry’s more notable CI executives. ArchIntel™ -.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104

ArchIntel

JANUARY 13, 2021

Executive Profile: Stefanie Kowitt, Capture Excellence and CI Team Lead at Lockheed Martin. Kowitt is a 20-year industry veteran whose career is focused on providing market research , competitive intelligence , data analysis , strategic planning and program management for companies that work on Department of Defense programs.

Competitive Intelligence 104

Competitive Intelligence Pharmaceutical Profiling Briefing 104

ArchIntel

APRIL 21, 2021

While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. Anupama Pokharna Senior Market, CI Manager Western Digital. As of 2019, there were some 12.8

Competitive Intelligence 104

Competitive Intelligence Profiling Competitive Pharmaceutical 104

ArchIntel

MARCH 17, 2021

These are the profiles of some of them. Executive Profile: Arnold DuBell, Associate Competitive and Strategic Intelligence Director at Novartis. Prior to working at Novartis, he spent 12 years at Kantar Health , a life sciences company headquartered in New York, according to his LinkedIn profile.

Pharmaceutical 104

Pharmaceutical Competitive Competitive Intelligence Profiling 104